SEARCH

SEARCH BY CITATION

References

  • 1
    Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005; 11: 2931.
  • 2
    Robson SC, Cooper DKC, D'Apice AJF. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000; 7: 166176.
  • 3
    Fuentes-Prior P, Iwanaga Y, Huber R et al. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature 2000; 404:518525.
  • 4
    Macias WL, Yan SB, Williams MD et al. New insights into the protein C pathway: Potential implications for the biological activities of drotrecogin alfa (activated). Crit Care 2005; 9(4 Suppl): S38S45.
  • 5
    Fukudome K, Ye X, Tsuneyoshi N et al. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med 1998; 187: 10291035.
  • 6
    Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 1996; 93: 1021210216.
  • 7
    Taylor FB, Jr., Peer GT, Lockhart MS, Ferrell G, Esmon CT. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 2001; 97: 16851688.
  • 8
    Laszik Z, Mitro A, Taylor FB, Jr., Ferrell G, Esmon CT. Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation 1997; 96: 36333640.
  • 9
    Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29(Suppl 7): S48S51.
  • 10
    Esmon CT. Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 1995; 9: 946955.
  • 11
    Bode W. The structure of thrombin, a chameleon-like proteinase. J Thromb Haemost 2005; 3: 23792388.
  • 12
    Overduin M, De BT. The plot thickens: How thrombin modulates blood clotting. Nat Struct Biol 2000; 7: 267269.
  • 13
    Yang L, Manithody C, Rezaie AR. Activation of protein C by the thrombin-thrombomodulin complex: Cooperative roles of Arg-35 of thrombin and Arg-67 of protein C. Proc Natl Acad Sci USA 2006; 103: 879884.
  • 14
    Koeppe JR, Seitova A, Mather T, Komives EA. Thrombomodulin tightens the thrombin active site loops to promote protein C activation. Biochemistry 2005; 44: 1478414791.
  • 15
    Xu H, Bush LA, Pineda AO, Caccia S, Di Cera E. Thrombomodulin changes the molecular surface of interaction and the rate of complex formation between thrombin and protein C. J Biol Chem 2005; 280: 79567961.
  • 16
    Mosnier LO, Bouma BN. Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis. Arterioscler Thromb Vasc Biol 2006; 26: 24452453.
  • 17
    Kokame K, Zheng X, Sadler JE. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C. J Biol Chem 1998; 273: 1213512139.
  • 18
    Schneider M, Nagashima M, Knappe S, Zhao L, Morser J, Nesheim M. Amino acid residues in the P6-P′3 region of thrombin-activable fibrinolysis inhibitor (TAFI) do not determine the thrombomodulin dependence of TAFI activation. J Biol Chem 2002; 277: 99449951.
  • 19
    Campbell WD, Lazoura E, Okada N, Okada H. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol Immunol 2002; 46: 131134.
  • 20
    Shinohara T, Sakurada C, Suzuki T et al. Pro-carboxypeptidase R cleaves bradykinin following activation. Int Arch Allergy Immunol 1994; 103: 400404.
  • 21
    Conway EM, Van de WM, Pollefeyt S et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 2002; 196: 565577.
  • 22
    Abeyama K, Stern DM, Ito Y et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest 2005; 115: 12671274.
  • 23
    Siegel JB, Grey ST, Lesnikoski B-A et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 1997; 64: 888896.
  • 24
    Kopp CW, Grey ST, Siegel JB et al. Expression of human thrombomodulin cofactor activity in porcine endothelial cells. Transplantation 1998; 66: 244251.
  • 25
    Kawakatsu T, Ogita H, Fukuhara T et al. Vav2 as a Rac-GDP/GTP exchange factor responsible for the nectin-induced, c-Src- and Cdc42-mediated activation of Rac. J Biol Chem 2005; 280: 49404947.
  • 26
    Bendtsen JD, Nielsen H, Von HG, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004; 340: 783795.
  • 27
    Nagashima M, Lundh E, Leonard JC, Morser J, Parkinson JF. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. J Biol Chem 1993; 268: 28882892.
  • 28
    Wood MJ, Sampoli Benitez BA, Komives EA. Solution structure of the smallest cofactor-active fragment of thrombomodulin. Nat Struct Biol 2000; 7: 200204.
  • 29
    Wang W, Nagashima M, Schneider M, Morser J, Nesheim M. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation. J Biol Chem 2000; 275: 2294222947.
  • 30
    Gerlitz B, Hassell T, Vlahos CJ, Parkinson JF, Bang NU, Grinnell BW. Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: Potential regulation of functionality by glycosyltransferase competition for serine474. Biochem J 1993; 295(Pt 1): 131140.
  • 31
    Chen Y, Tan W, Lu X et al. Full-length cDNA cloning and protein three-dimensional structure modeling of porcine prothrombin. Blood Cells Mol Dis 2007; 38: 9399.
  • 32
    Hall SW, Nagashima M, Zhao L, Morser J, Leung LL. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. J Biol Chem 1999; 274: 2551025516.
  • 33
    Lawson JH, Daniels LJ, Platt JL. The evaluation of thrombomodulin activity in porcine to human xenotransplantation. Transplant Proc 1997; 29: 884885.
  • 34
    Schulte am Esch EJ, Rogiers X, Robson SC. Molecular incompatibilities in hemostasis between swine and men-impact on xenografting. Ann Transplant 2001; 6: 1216.
  • 35
    Kunz G, Ireland HA, Stubbs PJ, Kahan M, Coulton GC, Lane DA. Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction. Blood 2000; 95: 569576.
  • 36
    Hasegawa N, Kandra TG, Husari AW et al. The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats. Am J Respir Crit Care Med 1996; 153(6 Pt 1): 18311837.
  • 37
    Kaneko H, Joubara N, Yoshino M et al. Protective effect of human urinary thrombomodulin on ischemia- reperfusion injury in the canine liver. Eur Surg Res 2000; 32: 8793.
  • 38
    Mohri M, Gonda Y, Oka M et al. The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis). Blood Coagul Fibrinolysis 1997; 8: 274283.
  • 39
    Takahashi Y, Hosaka Y, Imada K, Adachi T, Niina H, Mochizuki H. Species specificity of the anticoagulant activity of human urinary soluble thrombomodulin. Thromb Res 1998; 89: 187197.
  • 40
    Rose AG, Cooper DKC. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 2000; 7: 3141.
  • 41
    Shimizu A, Meehan SM, Kozlowski T et al. Acute humoral xenograft rejection: Destruction of the microvascular capillary endothelium in pig-to-nonhuman primate renal grafts. Lab Invest 2000; 80: 815830.
  • 42
    Shiraishi M, Oshiro T, Taira K et al. Improved hepatic microcirculation by human soluble urinary thrombomodulin in the xeno-perfused porcine liver. Transplantation 2001; 71: 10461050.